Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for EPTIFIBATIDE
- Platelet Function in Patients With Ischemic Stroke Treated With Anti-thrombotic or Thrombolytic
- Effect of Upstream High Bolus Dose of Tirofiban in Primary PCI for the Patients With STEMI on Short Term Outcome
- Cangrelor in Comatose Survivors of OHCA Undergoing Primary PCI
- Eptifibatide in Endovascular Treatment of Acute Ischemic Stroke (EPOCH)
- Multi-arm Optimization of Stroke Thrombolysis
- Crushed Ticagrelor Versus Eptifibatide Bolus + Clopidogrel
- Co-administration of Iloprost and Eptifibatide in Septic Shock Patients
- Therapeutic Equivalence Between Branded and Generic WARFArin Tablets in Brazil
- Study of the Combination Therapy of Rt-PA and Eptifibatide to Treat Acute Ischemic Stroke (CLEAR-FDR)
- Ticagrelor and Eptifibatide Bolus-Only Versus Ticagrelor and Eptifibatide Bolus Plus Abbreviated Infusion
- Clinical Effects of Eptifibatide Administration in High Risk Patients Presenting With Non-ST Segment Elevation Acute Coronary Syndrome (NSTE-ACS) Requiring Urgent Coronary Artery Bypass Graft Surgery in Short- and Long-Term Follow-up
- Integrilin and Ilomedin in Combination in Comparison to Standard Treatment in Severe Pneumonia Patients With Severe Sepsis
- Shortened Aggrastat® Versus Integrilin in Percutaneous Coronary Intervention
- The INtegrilin Plus STenting to Avoid Myocardial Necrosis Trial (INSTANT)
- Aspirin Resistance and Percutaneous Coronary Intervention (PCI)
- Effect of Otamixaban Versus Unfractionated Heparin + Eptifibatide in Patients With Unstable Angina/Non ST Elevation Myocardial Infarction Undergoing Early Invasive Strategy
- Comparison of Drug Eluting and Bare Metal Stents With or Without Abciximab in ST Elevation Myocardial Infarction
- Effectiveness of Intracoronary Injection of Eptifibatide in Primary Coronary Intervention in STEMI Patients
- Efficacy of Abciximab Bolus Only Regimen in Providing Inhibition of Platelet Action Over Time
- Study of the Combination Therapy of Rt-PA and Eptifibatide to Treat Acute Ischemic Stroke
- A Safety Study of Eptifibatide in Patients With Sickle Cell Disease
- Eptifibatide and ST Segment Resolution Following Primary PCI
- A Safety/Efficacy Study of Intracoronary Integrilin to Improve Balloon Angioplasty Outcomes for the Treatment of Heart Attacks
- INSTANT: INtegrilin Plus STenting to Avoid Myocardial Necrosis Trial
- Efficacy Of Eptifibatide Compared To Abciximab In Primary Percutaneous Coronary Intervention (PCI) For Acute ST Elevation Myocardial Infarction (STEMI)
- Abciximab in Patients Undergoing Percutaneous Coronary Intervention for Cardiogenic Shock
- PIoglitazone for PrEvention of Restenosis in Diabetic Patients
- Randomized Comparison of Abciximab Plus Heparin With Bivalirudin in Acute Coronary Syndrome
- Peri-Procedural Myocardial Infarction, Platelet Reactivity, Thrombin Generation, and Clot Strength: Differential Effects of Eptifibatide + Bivalirudin Versus Bivalirudin
- Study of Otamixaban Versus Unfractionated Heparin (UFH) and Eptifibatide in Non-ST Elevation Acute Coronary Syndrome
- Randomized Study of Aspirin Resistant Patients Undergoing Angioplasty
- Safety and Efficacy Study of Eptifibatide in Primary Percutaneous Coronary Intervention (PCI)
- Combined Approach to Lysis Utilizing Eptifibatide and rt-PA in Acute Ischemic Stroke (CLEAR Stroke) Trial
- BRIEF-PCI: Brief Infusion of Eptifibatide Following Percutaneous Coronary Intervention
- EARLY ACS: Early Glycoprotein IIb/IIIa Inhibition in Patients With Non-ST-segment Elevation Acute Coronary Syndrome (Study P03684AM2)(COMPLETED)
- Combination Anti-Platelet and Anti-Coagulation Treatment After Lysis of Ischemic Stroke Trial (CATALIST)
Clinical trials list
click for details